Abstract
As health care becomes increasingly personalized to the needs and values of individual patients, informational interventions that aim to inform and debias consumer decision-making are likely to become important tools. In a randomized controlled experiment, we explore the effects of providing participants with published fact boxes on the benefits and harms of common cancer screening procedures. Female participants were surveyed about breast cancer screening by mammography, while male participants were surveyed about prostate cancer screening by prostate-specific antigen (PSA) testing. For these screening procedures, we expect consumers to have overly optimistic prior beliefs about the benefits and harms. We find that participants update their beliefs about the net benefits of screening modestly, but we observe little change in their stated preferences to seek screening. Participants who scored higher on a numeracy test updated their beliefs about screening benefits more in response to the fact boxes than did participants who scored lower on the numeracy test.
Similar content being viewed by others
Data availability
Data are available upon request.
Notes
If, for example, we assume that \( \overrightarrow{\mathbf{s}}\sim N\left(\overrightarrow{\boldsymbol{\theta}},\Sigma \right) \) and the prior distribution is given by \( \boldsymbol{\Pi} \left(\overrightarrow{\boldsymbol{\theta}}\right)\sim N\left({\overrightarrow{\boldsymbol{m}}}_i,\Omega \right) \), then the posterior mean \( {\overrightarrow{\boldsymbol{m}}}_{i,j}^{\ast } \) for individual i who experiences the equivalent of n draws of signal \( \overrightarrow{\mathbf{s}} \) is given by the following expression (Bolstad and Curran 2016):
$$ {\displaystyle \begin{array}{c}{\overrightarrow{\boldsymbol{m}}}_{i,j}^{\ast }={\left[{\Omega}^{-1}+n{\varSigma}^{-1}\right]}^{-1}\left({\Omega}^{-1}{\overrightarrow{\boldsymbol{m}}}_i+n{\varSigma}^{-1}\overrightarrow{\mathbf{s}}\right)\\ {}{\overrightarrow{\boldsymbol{m}}}_{i,j}^{\ast }={\left[{\Omega}^{-1}+n{\varSigma}^{-1}\right]}^{-1}{\Omega}^{-1}{\overrightarrow{\boldsymbol{m}}}_i+{\left[{\Omega}^{-1}+n{\varSigma}^{-1}\right]}^{-1}n{\varSigma}^{-1}\overrightarrow{\mathbf{s}}\end{array}} $$We can represent the informational content of \( \overrightarrow{\mathbf{s}} \) and \( {\overrightarrow{\boldsymbol{m}}}_i \) as ξ = nΣ−1 and γ = Ω−1 and the relative informational content of the signal compared with the prior as Ψ = γ−1ξ. The posterior then simplifies to:
$$ {\overrightarrow{\boldsymbol{m}}}_{i,j}^{\ast }={\left[{I}_m+\Psi \right]}^{-1}\left({\overrightarrow{\boldsymbol{m}}}_i+\Psi \overrightarrow{\mathbf{s}}\right) $$We generalize from this result by assuming that the perceived relative information of the signal varies depending on individual- and source-specific factors.
We note that this research design allows us to examine how the distributions of outcomes change across the treatment and control arms, but it cannot allow us to identify the counterfactual outcomes for a particular individual assigned to one of these groups.
Subjects could provide more than one response to a question asking about their exposure to people with the cancer of interest (either breast or prostate cancer). Subjects who indicated both that they did not know anyone with the indicated cancer and that they knew certain individuals with the indicated cancer were classified as providing inconsistent responses.
We note that combined (subjective and objective) numeracy scores (coefficient = −0.073; p = 0.016) and subjective numeracy scores (coefficient = −0.060; p = 0.002) but not objective numeracy scores (coefficient = −0.048; p = 0.22) predicted treatment status in multivariable analysis. These results suggest that the treatment and control groups might not have been balanced on subjective numeracy, either due to differential completion rates and/or due to the treatment affecting later responses (e.g., the provision of health risk information might have caused individuals to rate their subjective proficiency with numbers lower). Given the potential for the subjective numeracy score to have been affected by the experimental treatment, we focus on results corresponding to objective numeracy.
Most or all of the 48 second difference may be explained by the 30 second pause imposed on treatment-group respondents when first viewing the fact box and the two additional questions they answered.
References
Adler, M. D., Dolan, P., & Kavetsos, G. (2017). Would you choose to be happy? Tradeoffs between happiness and the other dimensions of life in a large population survey. Journal of Economic Behavior & Organization, 139, 60–73.
American Cancer Society. (2020). Cancer facts and figures. Atlanta: American Cancer Society.
Amit, E., & Greene, J. D. (2012). You see, the ends don’t justify the means: Visual imagery and moral judgment. Psychological Science, 23(8), 861–868.
Barry, M. J., & Edgman-Levitan, S. (2012). Shared decision making—The pinnacle of patient-centered care. New England Journal of Medicine, 366(9), 780–781.
Basu, A., Jena, A. B., & Philipson, T. J. (2011). The impact of comparative effectiveness research on health and health care spending. Journal of Health Economics, 30(4), 695–706.
Bernheim, B. D. (2016). The good, the bad, and the ugly: A unified approach to behavioral welfare economics. Journal of Benefit-Cost Analysis, 7(1), 12–68.
Beshears, J., Choi, J. J., Laibson, D., Madrian, B. C., & Wang, S. Y. (2015). Who is easier to nudge? NBER Working Paper 401.
Black, W. C., Nease Jr., R. F., & Tosteson, A. N. (1995). Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. JNCI: Journal of the National Cancer Institute, 87(10), 720–731.
Bolstad, W. M., & Curran, J. M. (2016). Introduction to Bayesian statistics. John Wiley & Sons.
Bordalo, P., Gennaioli, N., & Shleifer, A. (2020). Memory, attention, and choice. Quarterly Journal of Economics, 135(3), 1399–1442.
Brot-Goldberg, Z. C., Chandra, A., Handel, B. R., & Kolstad, J. T. (2017). What does a deductible do? The impact of cost-sharing on health care prices, quantities, and spending dynamics. The Quarterly Journal of Economics, 132(3), 1261–1318.
Cooper, G. S., & Doug Kou, T. (2008). Underuse of colorectal cancer screening in a cohort of Medicare beneficiaries. Cancer: Interdisciplinary International Journal of the American Cancer Society, 112(2), 293–299.
Denberg, T. D., Wong, S., & Beattie, A. (2005). Women’s misconceptions about cancer screening: Implications for informed decision-making. Patient Education and Counseling, 57(3), 280–285.
Domenighetti, G., D’Avanzo, B., Egger, M., Berrino, F., Perneger, T., Mosconi, P., & Zwahlen, M. (2003). Women’s perception of the benefits of mammography screening: Population-based survey in four countries. International Journal of Epidemiology, 32(5), 816–821.
Edwards, A., & Elwyn, G. (2009). Shared decision-making in health care: Achieving evidence-based patient choice. Oxford University Press.
Elshaug, A. G., Rosenthal, M. B., Lavis, J. N., Brownlee, S., Schmidt, H., Nagpal, S., Littlejohns, P., Srivastava, D., Tunis, S., & Saini, V. (2017). Levers for addressing medical underuse and overuse: Achieving high-value health care. The Lancet, 390(10090), 191–202.
Elwyn, G., Edwards, A., & Thompson, R. (2016). Shared decision making in health care: Achieving evidence-based patient choice (3ed ed.). Oxford: Oxford University Press.
Fagerlin, A., Zikmund-Fisher, B. J., Ubel, P. A., Jankovic, A., Derry, H. A., & Smith, D. M. (2007). Measuring numeracy without a math test: Development of the subjective numeracy scale. Medical Decision Making, 27(5), 672–680.
Frosch, D. L., Kaplan, R. M., & Felitti, V. J. (2003). A randomized controlled trial comparing internet and video to facilitate patient education for men considering the prostate specific antigen test. Journal of General Internal Medicine, 18(10), 781–787.
Gigerenzer, G. (2014). Breast cancer screening pamphlets mislead women. Bmj, 348 (Apr 25), g2636.
Gigerenzer, G., Gaissmaier, W., Kurz-Milcke, E., Schwartz, L. M., & Woloshin, S. (2007). Helping doctors and patients make sense of health statistics. Psychological Science in the Public Interest, 8(2), 53–96.
Gigerenzer, G., & Kolpatzik, K. (2017). How new fact boxes are explaining medical risk to millions. Bmj, 357, j2460.
Gigerenzer, G., Mata, J., & Frank, R. (2009). Public knowledge of benefits of breast and prostate cancer screening in Europe. Journal of the National Cancer Institute, 101(17), 1216–1220.
Golman, R., Hagmann, D., & Loewenstein, G. (2017). Information avoidance. Journal of Economic Literature, 55(1), 96–135.
Grossman, D. C., Curry, S. J., Owens, D. K., Bibbins-Domingo, K., Caughey, A. B., Davidson, K. W., et al. (2018). Screening for prostate cancer: US Preventive Services Task Force recommendation statement. JAMA, 319(18), 1901–1913.
Grüne-Yanoff, T., & Hertwig, R. (2016). Nudge versus boost: How coherent are policy and theory? Minds and Machines, 26(1–2), 149–183.
Hammitt, J. K., & Graham, J. D. (1999). Willingness to pay for health protection: Inadequate sensitivity to probability? Journal of Risk and Uncertainty, 18(1), 33–62.
Handel, B. R., & Kolstad, J. T. (2015). Health insurance for “humans”: Information frictions, plan choice, and consumer welfare. American Economic Review, 105(8), 2449–2500.
Hertwig, R. (2017). When to consider boosting: Some rules for policy-makers. Behavioural Public Policy, 1(2), 143–161.
Hertwig, R., & Ryall, M. D. (2019). Nudge versus boost: Agency dynamics under libertarian paternalism. The Economic Journal, 130(629), 1384–1415. https://doi.org/10.1093/ej/uez054.
Hoffrage, U., & Gigerenzer, G. (1998). Using natural frequencies to improve diagnostic inferences. Academic Medicine, 73(5), 538–540.
Houwer, J. D., & Hermans, D. (1994). Differences in the affective processing of words and pictures. Cognition & Emotion, 8(1), 1–20.
Johnson, E. J., Hassin, R., Baker, T., Bajger, A. T., & Treuer, G. (2013). Can consumers make affordable care affordable? The value of choice architecture. PLoS One, 8(12), e81521.
Johnson, E. J., Shu, S. B., Dellaert, B. G., Fox, C., Goldstein, D. G., Häubl, G., et al. (2012). Beyond nudges: Tools of a choice architecture. Marketing Letters, 23(2), 487–504.
Jørgensen, K. J., Keen, J. D., & Gøtzsche, P. C. (2011). Is mammographic screening justifiable considering its substantial overdiagnosis rate and minor effect on mortality? Radiology, 260(3), 621–627.
Joseph-Williams, N., Elwyn, G., & Edwards, A. (2014). Knowledge is not power for patients: A systematic review and thematic synthesis of patient-reported barriers and facilitators to shared decision making. Patient Education and Counseling, 94(3), 291–309.
Keating, N. L., & Pace, L. E. (2018). Breast cancer screening in 2018: Time for shared decision making. JAMA, 319(17), 1814–1815.
Kling, J. R., Mullainathan, S., Shafir, E., Vermeulen, L. C., & Wrobel, M. V. (2012). Comparison friction: Experimental evidence from Medicare drug plans. The Quarterly Journal of Economics, 127(1), 199–235.
Kuzujanakis, M., Kleinman, K., Rifas-Shiman, S., & Finkelstein, J. A. (2003). Correlates of parental antibiotic knowledge, demand, and reported use. Ambulatory Pediatrics, 3(4), 203–210.
Levy, H., Ubel, P. A., Dillard, A. J., Weir, D. R., & Fagerlin, A. (2014). Health numeracy: The importance of domain in assessing numeracy. Medical Decision Making, 34(1), 107–115.
Lipkus, I. M., Peters, E., Kimmick, G., Liotcheva, V., & Marcom, P. (2010). Breast cancer patients’ treatment expectations after exposure to the decision aid program adjuvant online: The influence of numeracy. Medical Decision Making, 30(4), 464–473.
Lipkus, I. M., Samsa, G., & Rimer, B. K. (2001). General performance on a numeracy scale among highly educated samples. Medical Decision Making, 21(1), 37–44.
Loehrer Sr., P. J., Greger, H. A., Weinberger, M., Musick, B., Miller, M., Nichols, C., et al. (1991). Knowledge and beliefs about cancer in a socioeconomically disadvantaged population. Cancer, 68(7), 1665–1671.
McDowell, M., Gigerenzer, G., Wegwarth, O., & Rebitschek, F. G. (2019). Effect of tabular and icon fact box formats on comprehension of benefits and harms of prostate cancer screening: A randomized trial. Medical Decision Making, 39(1), 41–56.
McDowell, M., Rebitschek, F. G., Gigerenzer, G., & Wegwarth, O. (2016). A simple tool for communicating the benefits and harms of health interventions: A guide for creating a fact box. MDM Policy & Practice, 1(1), 2381468316665365.
Moyer, V. A. (2012). Screening for prostate cancer: US preventive services task force recommendation statement. Annals of Internal Medicine, 157(2), 120–134.
Neumann, P. J., Cohen, J. T., Hammitt, J. K., Concannon, T. W., Auerbach, H. R., Fang, C., & Kent, D. M. (2012). Willingness-to-pay for predictive tests with no immediate treatment implications: A survey of US residents. Health Economics, 21(3), 238–251.
Pandya, A. (2018). Adding cost-effectiveness to define low-value care. JAMA, 319(19), 1977–1978. https://doi.org/10.1001/jama.2018.2856.
Peters, E., Tompkins, M. K., Knoll, M. A., Ardoin, S. P., Shoots-Reinhard, B., & Meara, A. S. (2019). Despite high objective numeracy, lower numeric confidence relates to worse financial and medical outcomes. Proceedings of the National Academy of Sciences, 116(39), 19386–19391.
Peters, E., Västfjäll, D., Slovic, P., Mertz, C., Mazzocco, K., & Dickert, S. (2006). Numeracy and decision making. Psychological Science, 17(5), 407–413.
Rheinberger, C. M., & Hammitt, J. K. (2018). Dinner with Bayes: On the revision of risk beliefs. Journal of Risk and Uncertainty, 57(3), 253–280.
Schwartz, L. M., Woloshin, S., & Welch, H. G. (2009). Using a drug facts box to communicate drug benefits and harms: Two randomized trials. Annals of Internal Medicine, 150(8), 516–527.
Shoag, J. E., Nyame, Y. A., Gulati, R., Etzioni, R., & Hu, J. (2020). Reconsidering the trade-offs of prostate cancer screening. The New England Journal of Medicine, 382(25), 2465–2468.
Sicsic, J., Pelletier-Fleury, N., & Moumjid, N. (2018). Women’s benefits and harms trade-offs in breast cancer screening: Results from a discrete-choice experiment. Value in Health, 21(1), 78–88.
Siu, A. L. (2016). Screening for breast cancer: US preventive services task force recommendation statement. Annals of Internal Medicine, 164(4), 279–296.
Smith, K. T., Monti, D., Mir, N., Peters, E., Tipirneni, R., & Politi, M. C. (2018). Access is necessary but not sufficient: Factors influencing delay and avoidance of health care services. MDM Policy & Practice, 3(1), 2381468318760298.
Smith, V. K., & Johnson, F. R. (1988). How do risk perceptions respond to information? The case of radon. The Review of Economics and Statistics, 1–8.
Sunstein, C. R. (2016). The ethics of influence: Government in the age of behavioral science. Cambridge University Press.
Sunstein, C. R. (2019). Ruining popcorn? The welfare effects of information. Journal of Risk and Uncertainty, 58(2–3), 121–142. https://doi.org/10.1007/s11166-019-09300-w.
Thaler, R. H., & Sunstein, C. R. (2009). Nudge: Improving decisions about health, wealth, and happiness. Penguin.
Thunström, L. (2019). Welfare effects of nudges: The emotional tax of calorie menu labeling. Judgment and Decision Making, 14(1), 11.
United States Preventive Services Task Force. (2009). Screening for breast cancer: US Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 151(10), 716.
Viscusi, W. K. (1989). Prospective reference theory: Toward an explanation of the paradoxes. Journal of Risk and Uncertainty, 2(3), 235–263.
Zellner, A. (1962). An efficient method of estimating seemingly unrelated regressions and tests for aggregation bias. Journal of the American Statistical Association, 57(298), 348–368.
Zizzo, D. J. (2010). Experimenter demand effects in economic experiments. Experimental Economics, 13(1), 75–98.
Acknowledgments
Arek Avedian provided valuable input on the design of survey questions and managed survey administration. Gregory Bruich, Dae Woong Ham, Tuna Hayirli, Yuli Hsieh, Masha Kuznetsova, Anna Zink, and an anonymous referee provided helpful comments. This project was supported in part by grant number T32HS000055 from the Agency for Healthcare Research and Quality. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality. Hammitt acknowledges funding from the French National Research Agency (ANR) under the Investments for the Future (Investissements d’Avenir) program, grant ANR-17-EURE-0010.
Code availability
Code for statistical analyses is available upon request.
Funding
This project was supported by grant number T32HS000055 from the Agency for Healthcare Research and Quality to MRE and grant ANR-17-EURE-0010 from the French National Research Agency to JKH.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest/competing interests
The authors report no conflicts of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
ESM 1
(PDF 1080 kb)
Rights and permissions
About this article
Cite this article
Eber, M.R., Sunstein, C.R., Hammitt, J.K. et al. The modest effects of fact boxes on cancer screening. J Risk Uncertain 62, 29–54 (2021). https://doi.org/10.1007/s11166-021-09344-x
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11166-021-09344-x